Kriya Therapeutics Completes $100 Million Series B Financing to Advance Its Fully Integrated Platform for Designing, Developing and Manufacturing Transformative Gene Therapies

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2VAe4qo
via IFTTT